Cerebrovascular events after herpes zoster infection: a risk that should be not underestimated
- 114 Downloads
The occurrence of a cerebrovascular event after a herpes zoster (HZ) infection represents a nightmare in clinical practice, especially in those patients with concomitant cardiovascular comorbidities/risk factors and disease related per se to a higher risk of zoster infection. Moreover, the absence of a consensus opinion regarding a specific and adequate prevention of cerebrovascular events in these patients further complicates the treatment. Accumulating evidences demonstrated that HZ and HZ ophtalmicus (HZO) increase the risk of cerebrovascular events in the short-and long-term periods. Moreover, patient’s ages < 40 years old, despite having fewer traditional cardiovascular comorbidities, demonstrated a higher risk of cerebrovascular events after both HZ and HZO infection. Further prospective studies are needed to analyse the role of antiviral treatments and vaccination in these subjects to clarify if they could be able to reduce the risk of stroke after a zoster infection. In the meanwhile, physicians must be aware of a higher risk of cerebrovascular events, especially in younger patients, with few cardiovascular risk factors, after an HZ infection.
KeywordsHerpes zoster Stroke Cerebrovascular events
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Gilden D (2015) Varicella-zoster virus infections. Continuum (Minneap Minn) 21(6 Neuroinfectious Disease):1692–1703Google Scholar
- Khan N, Patel D, Trivedi C, Shah Y, Lichtenstein G, Lewis J, Yang YX (2018) Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases: a Nationwide cohort study. Clin Gastroenterol Hepatol 16:1919-1927.e3. https://doi.org/10.1016/j.cgh.2017.12.052
- Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ (2003) Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 188(9):1336–1344CrossRefPubMedGoogle Scholar
- Liao CH, Chang CS, Muo CH, Kao CH (2015) High prevalence of herpes zoster in patients with depression. J Clin Psychiatry 76(9):e1099–e1104 https://doi.org/10.4088/JCP.14m09311
- Liao TL, Lin CH, Chen HH, Chen YM, Lin CC, Chen DY (2017) Significant associations of neurological complications of herpes zoster with stroke in rheumatoid arthritis patients. J Am Heart Assoc 6(7) 6:pii:e006304. https://doi.org/10.1161/JAHA.117.006304
- Nagel MA, Traktinskiy I, Azarkh Y, Kleinschmidt-DeMasters B, Hedley-Whyte T, Russman A, VanEgmond EM, Stenmark K, Frid M, Mahalingam R, Wellish M, Choe A, Cordery-Cotter R, Cohrs RJ, Gilden D (2011) Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology 77(4):364–370CrossRefPubMedPubMedCentralGoogle Scholar
- Papagianni M, Metallidis S, Tziomalos K (2018) Herpes zoster and diabetes mellitus: a review. Diabetes Ther 9(2):545–550 https://doi.org/10.1007/s13300-018-0394-4
- Zuin M, Rigatelli G, Picariello C, Carraro M, Zonzin P, Roncon L (2017) Prognostic role of a new risk index for the prediction of 30-day cardiovascular mortality in patients with acute pulmonary embolism: the Age-Mean Arterial Pressure Index (AMAPI). Heart Vessel 32(12):1478–1487CrossRefGoogle Scholar